loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 77702 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Aurobindo Pharma Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AUROBINDO (1)

    filter

    01 SUSPENSION;ORAL (1)

    filter

    01 RX (1)

    filter

    01 NEVIRAPINE (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    NEVIRAPINE

    PDF Supplier PDF
    URL Supplier Web Content
    SUSPENSION; ORAL
    50MG/5ML
    2012-05-22
    77702
    NEVIRAPINE
    RX
    No
    AA
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 77702

    Looking for FDA Orange Book APPLICATION 77702 1

    19

    Aurobindo Pharma Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is NEVIRAPINE, with a corresponding application number 77702.

    Regulatory Information RX

    With a dosage strength 50MG/5ML

    Dosage Form Route SUSPENSION; ORAL

    Reference Listed Drug No

    Approved since 2012-05-22

    Therapeutic Equivalence (TE) Code AA

    Post Enquiry
    POST ENQUIRY